Eargo, Inc.
EARDelisted Feb 16, 2024- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001719395
Eargo, Inc. was delisted on Feb 16, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 23 institutions reported holding it in 13F filings for Q4 2023, worth $44.2M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Eargo, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- −6 vs. Q4 2021
- Shares held
- 21.1M
- +613.3K (+3.0%) vs. Q4 2021
- Total value
- $111.8M
- +$7.17M (+6.9%) vs. Q4 2021
- New holders
- 14
- 27 more added
- Sold out
- 20
- 27 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 23 | $44.2M |
| Q3 2023 | 20 | $36.0M |
| Q2 2023 | 19 | $82.4M |
| Q1 2023 | 24 | $78.7M |
| Q4 2022 | 42 | $195.9M |
| Q3 2022 | 48 | $13.0M |
| Q2 2022 | 61 | $11.2M |
| Q1 2022 | 81 | $111.8M |
| Q4 2021 | 87 | $104.6M |
| Q3 2021 | 82 | $144.3M |
| Q2 2021 | 114 | $1.21B |
| Q1 2021 | 80 | $919.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Eargo, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −3,572−100.0% | Sold out |